WASHINGTON Oct 23 XDx Inc, a molecular
diagnostics company, filed with regulators on Tuesday to raise
up to $86.25 million in an initial public offering of common
The company said in a preliminary filing with the U.S.
Securities and Exchange Commission that JPMorgan, Morgan
Stanley, Piper Jaffray, and JMP Securities are underwriting the
XDx plans to list its stock on the Nasdaq under the symbol
The filing did not indicate how many shares the company
plans to sell or their expected price.